Literature DB >> 12646955

Fatal myelodysplastic syndrome developing during therapy with imatinib mesylate and characterised by the emergence of complex Philadelphia negative clones.

Y L Chee, M A Vickers, D Stevenson, T L Holyoake, D J Culligan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12646955     DOI： 10.1038/sj.leu.2402842

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  6 in total

1.  Emergence of abnormal clone with monsomy 7 in Philadelphia negative cells of CML patients treated with tyrosine kinase inhibitors.

Authors:  Monika Ribeiro de Mello Conchon; Israel Bendit; Patricia Ferreira; Walter Lima; Cristina Kumeda; Lucia Dias; Dalton de Alencar Fischer Chamone; Pedro Enrique Dorlhiac-Llacer
Journal:  Int J Hematol       Date:  2008-12-18       Impact factor: 2.490

2.  Philadelphia chromosome-negative acute myeloid leukemia with 11q23/MLL translocation in a patient with chronic myelogenous leukemia.

Authors:  Vanya Jaitly; Wei Wang; Shimin Hu
Journal:  Stem Cell Investig       Date:  2015-07-01

Review 3.  Monitoring BCR-ABL in the treatment of chronic myeloid leukemia by polymerase chain reaction.

Authors:  Vivian G Oehler; Jerald P Radich
Journal:  Curr Hematol Malig Rep       Date:  2006-09       Impact factor: 3.952

4.  Molecular measurement of BCR-ABL transcript variations in chronic myeloid leukemia patients in cytogenetic remission.

Authors:  Mariana Serpa; Sabri S Sanabani; Pedro Enrique Dorliac-Llacer; Monika Conchon; Thales Dalessandro Meneguin Pereira; Luciana Nardinelli; Juliana Lima Costa; Mafalda Megumi Yoshinaga Novaes; Patricia de Barros Ferreira; Israel Bendit
Journal:  BMC Blood Disord       Date:  2010-11-18

5.  Secondary myelodysplastic syndrome in a patient with Philadelphia-positive acute lymphoblastic leukemia after achieving a major molecular response with hyperCVAD plus imatinib mesylate.

Authors:  Arturo Vega-Ruiz; Susan O'Brien; Jorge Cortes; Partow Kebriaei; Deborah Thomas; Hagop Kantarjian; Farhad Ravandi
Journal:  Leuk Res       Date:  2008-03-19       Impact factor: 3.156

6.  Chromosomal rearrangement involving 11q23 locus in chronic myelogenous leukemia: a rare phenomenon frequently associated with disease progression and poor prognosis.

Authors:  Wei Wang; Guilin Tang; Jorge E Cortes; Hui Liu; Di Ai; C Cameron Yin; Shaoying Li; Joseph D Khoury; Carlos Bueso-Ramos; L Jeffrey Medeiros; Shimin Hu
Journal:  J Hematol Oncol       Date:  2015-04-08       Impact factor: 17.388
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.